Search by Drug Name or NDC

    NDC 70934-0216-30 Clindamycin hydrochloride 150 mg/1 Details

    Clindamycin hydrochloride 150 mg/1

    Clindamycin hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Denton Pharma, Inc. dba Northwind Pharmaceuticals. The primary component is CLINDAMYCIN HYDROCHLORIDE.

    Product Information

    NDC 70934-0216
    Product ID 70934-216_d6f97aac-8a7e-33c8-e053-2995a90a55a1
    Associated GPIs 16220020100110
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Clindamycin hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Clindamycin hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name CLINDAMYCIN HYDROCHLORIDE
    Labeler Name Denton Pharma, Inc. dba Northwind Pharmaceuticals
    Pharmaceutical Class Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA065061
    Listing Certified Through n/a

    Package

    NDC 70934-0216-30 (70934021630)

    NDC Package Code 70934-216-30
    Billing NDC 70934021630
    Package 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-216-30)
    Marketing Start Date 2018-12-20
    NDC Exclude Flag N
    Pricing Information N/A